YÜCE İNEL, T. Et Al. 2025. Does the Presence of Comorbidities in Rheumatoid Arthritis Patients Impact Initial Tumor Necrosis Factor Inhibitor Treatment Response and Retention Rates?. JOURNAL OF HEALTH SCIENCES AND MEDICINE , vol.8, no.2 , 292-297.

YÜCE İNEL, T., KOCAER, S. B., DALKILIÇ, H. E., AKAR, S., KOCA, S. S., ŞENEL, A. S., ... TUFAN, A.(2025). Does the Presence of Comorbidities in Rheumatoid Arthritis Patients Impact Initial Tumor Necrosis Factor Inhibitor Treatment Response and Retention Rates?. JOURNAL OF HEALTH SCIENCES AND MEDICINE , vol.8, no.2, 292-297.

YÜCE İNEL, TUBA Et Al. "Does the Presence of Comorbidities in Rheumatoid Arthritis Patients Impact Initial Tumor Necrosis Factor Inhibitor Treatment Response and Retention Rates?," JOURNAL OF HEALTH SCIENCES AND MEDICINE , vol.8, no.2, 292-297, 2025

YÜCE İNEL, TUBA Y. Et Al. "Does the Presence of Comorbidities in Rheumatoid Arthritis Patients Impact Initial Tumor Necrosis Factor Inhibitor Treatment Response and Retention Rates?." JOURNAL OF HEALTH SCIENCES AND MEDICINE , vol.8, no.2, pp.292-297, 2025

YÜCE İNEL, T. Et Al. (2025) . "Does the Presence of Comorbidities in Rheumatoid Arthritis Patients Impact Initial Tumor Necrosis Factor Inhibitor Treatment Response and Retention Rates?." JOURNAL OF HEALTH SCIENCES AND MEDICINE , vol.8, no.2, pp.292-297.

@article{article, author={TUBA YÜCE İNEL Et Al. }, title={Does the Presence of Comorbidities in Rheumatoid Arthritis Patients Impact Initial Tumor Necrosis Factor Inhibitor Treatment Response and Retention Rates?}, journal={JOURNAL OF HEALTH SCIENCES AND MEDICINE}, year=2025, pages={292-297} }